WPG Advisers’s Adaptive Biotechnologies ADPT Stock Holding History

WPG Advisers’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.39K	Hold	158	–	–	﹤0.01%	1069
2026 Q1	$2.19K	Hold	158	–	–	﹤0.01%	1061
2025 Q4	$2.57K	Buy	+158	New	+$2.58K	﹤0.01%	1066

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WPG Advisers's ADPT Position: Q2 2026 in Review

WPG Advisers held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 158 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

WPG Advisers first reported a position in ADPT in Q4 2025 and has held it in 3 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

WPG Advisers held 158 shares of Adaptive Biotechnologies worth $3.39K as of Q2 2026.
WPG Advisers left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1069 holding.
WPG Advisers first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 3 quarters since.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.